Skip to main content

Table 1 Demographic and clinical characteristics of adults and children with a positive or negative SARS-CoV-2 test result

From: Association between SARS-CoV-2 infection and select symptoms and conditions 31 to 150 days after testing among children and adults

Characteristic

Adults (≥20 years old)

Children and young adults (0 -19 years)

Non-hospitalized

Hospitalized

Non-hospitalized

Hospitalized

Positive

Negative

Positive

Negative

Positive

Negative

Positive

Negative

No. with a SARS-CoV-2 test during March 1st, 2020—May 31st, 2021 AND had any diagnosis in the 540 to 31 days prior to the index date AND a diagnosis in the 31 to 150 days following the index date

270441

2102408

45808

672923

59374

520,816

2757

92696

Age in years, mean (SD)

48.9 (16.8)

52.8 (17.4)

59.9 (17.3)

55.9 (18.4)

10.2 (6.1)

8.3 (6.1)

10.3 (6.5)

8.9 (6.3)

Age Group, years (N, % of patients)

 0 - < 1

NA

NA

NA

NA

4969 (8.4)

51144 (9.8)

320 (11.6)

11649 (12.6)

 1 - < 2

NA

NA

NA

NA

3769 (6.3)

50312 (9.7)

189 (6.9)

7415 (8.0)

 2 - < 6

NA

NA

NA

NA

8797 (14.8)

114730 (22.0)

373 (13.5)

16778 (18.1)

 6 - < 13

NA

NA

NA

NA

14983 (25.2)

142459 (27.4)

538 (19.5)

22058 (23.8)

 13 - < 18

NA

NA

NA

NA

18512 (31.2)

115487 (22.2)

883 (32.0)

25433 (27.4)

 18 - < 20

NA

NA

NA

NA

8344 (14.1)

46684 (9.0)

454 (16.5)

9363 (10.1)

 20 - < 40

89892 (33.2)

571146 (27.2)

7361 (16.1)

172046 (25.6)

NA

NA

NA

NA

 40 - < 55

75190 (27.8)

492470 (23.4)

8365 (18.3)

117210 (17.4)

NA

NA

NA

NA

 55 - < 65

51300 (19.0)

421607 (20.1)

9867 (21.5)

128344 (19.1)

NA

NA

NA

NA

 65 - < 75

34331 (12.7)

379716 (18.1)

10064 (22.0)

138562 (20.6)

NA

NA

NA

NA

 75 - < 85

15191 (5.6)

185106 (8.8)

7176 (15.7)

85028 (12.6)

NA

NA

NA

NA

 85 + 

4537 (1.7)

52363 (2.5)

2975 (6.5)

31733 (4.7)

NA

NA

NA

NA

Sex (N, % of patients)

 Female

170017 (62.9)

1292859 (61.5)

24975 (54.5)

405346 (60.2)

30502 (51.4)

255450 (49.0)

1406 (51.0)

46404 (50.1)

 Male

100409 (37.1)

809350 (38.5)

20829 (45.5)

267541 (39.8)

28868 (48.6)

265341 (51.0)

1351 (49.0)

46286 (49.9)

 Other/Missinga

13 (0.0)

199 (0.0)

1–5 (0.0)

26 (0.0)

1–5 (0.0)

25 (0.0)

0 (0.0)

6–10 (0.0)

Race (N, % of patients)

 Asian

7158 (2.6)

61996 (2.9)

1140 (2.5)

17951 (2.7)

1620 (2.7)

15509 (3.0)

70 (2.5)

3179 (3.4)

 Black or African American

42899 (15.9)

329438 (15.7)

11906 (26.0)

121268 (18.0)

9874 (16.6)

79953 (15.4)

686 (24.9)

16630 (17.9)

 White

186703 (69.0)

1474317 (70.1)

24631 (53.8)

461579 (68.6)

37308 (62.8)

338040 (64.9)

1268 (46.0)

56192 (60.6)

 Otherb

21417 (7.9)

150712 (7.2)

6161 (13.4)

52651 (7.8)

6768 (11.4)

55905 (10.7)

582 (21.1)

12626 (13.6)

 Missingc

12254 (4.5)

85945 (4.1)

1962 (4.3)

19471 (2.9)

3788 (6.4)

31405 (6.0)

151 (5.5)

4056 (4.4)

Ethnicity (N, % of patients)

 Hispanic

44275 (16.4)

201931 (9.6)

8455 (18.5)

63904 (9.5)

13739 (23.1)

83228 (16.0)

781 (28.3)

14557 (15.7)

 Non-Hispanic

206370 (76.3)

1683892 (80.1)

34761 (75.9)

569136 (84.6)

42440 (71.5)

401034 (77.0)

1898 (68.8)

74749 (80.6)

 Other

1491 (0.6)

23112 (1.1)

50 (0.1)

643 (0.1)

173 (0.3)

2147 (0.4)

1–5 (0.0)

353 (0.4)

 Missingc

18305 (6.8)

193473 (9.2)

2538 (5.5)

39237 (5.8)

3014 (5.1)

34407 (6.6)

76–80 (2.8)

3035 (3.3)

BMI (N, % of patients)

 Obesityd

97082 (35.9)

661683 (31.5)

18889 (41.2)

243020 (36.1)

9372 (15.8)

74928 (14.4)

582 (21.1)

15767 (17.0)

 Missing BMI

72210 (26.7)

511513 (24.3)

9946 (21.7)

115278 (17.1)

16826 (28.3)

135253 (26.0)

546 (19.8)

16783 (18.1)

Number of visits in the 31 to 150 days before the index event, mean (SD)

5.4 (6.8)

5.5 (6.8)

7.6 (9.0)

8.0 (8.4)

3.7 (5.7)

4.0 (6.3)

10.8 (13.4)

7.7 (9.9)

Dexamethasone use (N, % of patients)

8822 (3.3)

188156 (8.9)

16112 (35.2)

143911 (21.4)

634 (1.1)

52284 (10.0)

511 (18.5)

27072 (29.2)

Length of hospital stay, days, mean (SD)

NA

NA

7.3 (139.8)

1.1 (277.7)

NA

NA

6.2 (12.7)

4.6 (41.9)

Mechanical ventilation (N, % of patients)

690 (0.3)

4484 (0.2)

2116 (4.6)

18520 (2.8)

57 (0.1)

2275 (0.4)

158 (5.7)

4305 (4.6)

Current smoker e (N, % of patients)

15923 (5.9)

176664 (8.4)

2257 (4.9)

59378 (8.8)

NA

NA

NA

NA

Combined comorbidity score, f mean (SD)

1.0 (2.1)

1.3 (2.3)

2.7 (3.3)

2.1 (2.9)

NA

NA

NA

NA

  1. Abbreviations: BMI Body mass index (calculated as weight in kilograms divided by height in meters squared), NA Not applicable
  2. aOther/missing sex includes no information, unknown, and other
  3. bOther race includes native Hawaiian or other pacific islander, American Indian or Alaska Native, multiple race, and all other races
  4. cMissing race and ethnicity includes refuse to answer, no information, unknown, and missing values
  5. dFor children, obesity was defined as BMI greater or equal to 95th percentile; for adults, obesity was defined as BMI ≥ 30 kg/m2
  6. eSmoking status was ascertained based on information in the EHR data. Smoking status was assessed for adults only
  7. fCombined comorbidity score was defined based on Gagne et al.’s combined comorbidity score. Combined comorbidity was assessed for adults only